Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cancer Screening in HF
Cancer Screening in HF

Short Communication

Author(s): Sean Tan , Grace JX Chung , Jasmine Chan , et al Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
Hospitalised HF: Ejection Fraction Analysis (MY-HF Registry)
Author(s): Wan Azman Wan Ahmad , Abdul Kahar Abdul Ghapar , Azmee Mohd Ghazi , et al Added: 1 year ago

Heart Failure
APSC Consensus Statements on Worsening Heart Failure
Author(s): David Sim , Weiqin Lin , Louis Teo , et al Added: 5 months ago

Guidelines & Statements

Heart Failure
HFSA 24: FINEARTS-HF Across the Ejection Fraction Spectrum
Author(s): Akshay S Desai Added: 1 year ago
HFSA 24 - Dr Akshay Desai (Brigham and Women’s Hospital, US) sits down with us to discuss the findings from FINEARTS-HF across the ejection fraction spectrum in heart failure with mildly reduced and preserved ejection fraction.Interview Questions:1. What was the reasoning behind this study? What was the study design and patient population?2. What was the study design and patient population?3… View more

Heart Failure
GDMT & Outcomes in HFrEF: Physician-led Multicentre Experience from Sarawak
Author(s): Rebecca Su Li Chew , Bui Khiong Chung , Hwei Sung Ling , et al Added: 1 month ago

Cardiovascular Kidney Metabolic

Guidelines & Statements
DIGIT-HF: Digitoxin Reduces Primary Outcome in Symptomatic Heart Failure with Reduced Ejection Fraction
Added: 7 months ago Source:  Radcliffe Cardiology
AUTHOR: Yazmin SadikNew findings from the DIGIT-HF trial indicate that adding low-dose digitoxin to guideline-directed medical therapy (GDMT) can reduce the risk of hospitalisation and all-cause mortality in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).¹The results were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously… View more

Imaging & Diagnostics

Guidelines & Statements
Coronary Revascularisation in HFrEF
Author(s): Bernhard Haring , Michael Böhm Added: 2 years ago

Prevention & Chronic Conditions

Heart Failure
Decoding the Future of HF — Key Takeaways from 2024
Author(s): Muthiah Vaduganathan , Orly Vardeny , Added: 1 year ago
Recorded at American Heart Association 2024 in Chicago, Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, Boston, US), Dr Orly Vardeny (University of Minnesota Medical School, Minneapolis, US) and Prof Pardeep Jhund (University of Glasgow, Glasgow, UK) explore cardiometabolic disease in heart failure with mid-range or preserved ejection fraction (HFmrEF and HFpEF)… View more

Heart Failure
HFA 24: The RELIEVE-HF Trial: Differential Effects of V-Wave Device
Author(s): Michael R Zile Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had… View more

Heart Failure
HFpEF in Patients Living with COPD
Author(s): Nadirah Abd Wahid , Aisya Natasya Musa , Sazzli Kasim , et al Added: 2 months ago

Heart Failure

Imaging & Diagnostics